NW
Nathan Weinstein Aegis Capital Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Evogene
EVGN
$10.5M
| $1.20 | $80 |
6,567%
upside
| Buy |
12 Sep ‘22
3 years ago |
|
2
DarioHealth
DRIO
$23M
| $9.60 | $300 |
3,025%
upside
| Buy |
18 Aug ‘22
3 years ago |
|
3
VolitionRX
VNRX
$64.8M
| $0.6020 | $6 |
897%
upside
| Buy |
15 Aug ‘22
3 years ago |
|
4
Immunic
IMUX
$75.1M
| $0.7610 | $35 |
4,499%
upside
| Buy |
8 Aug ‘22
3 years ago |
|
5
Stereotaxis
STXS
$264M
| $2.90 | $6 |
107%
upside
| Buy |
12 Jul ‘22
3 years ago |
|
6
Oramed Pharmaceuticals
ORMP
$91.4M
| $2.23 | $30 |
1,245%
upside
| Buy |
16 May ‘22
3 years ago |
|
7
Trevi Therapeutics
TRVI
$854M
| $7.01 | $10 |
43%
upside
| Buy |
29 Mar ‘22
3 years ago |
|
8
MediWound
MDWD
$177M
| $16.29 | $49 |
201%
upside
| Buy |
21 Mar ‘22
3 years ago |
|
9
Enveric Biosciences
ENVB
$2.95M
| $0.9100 | $150 |
16,384%
upside
| Hold |
8 Mar ‘22
3 years ago |
|
|
SCNI
10
Scinai Immunotherapeutics
SCNI
$1.5M
| $1.50 | $70 |
4,567%
upside
| Buy |
26 Jan ‘22
3 years ago |
|
11
Cingulate
CING
$21.1M
| $3.90 | $2,160 |
55,285%
upside
| Buy |
11 Jan ‘22
3 years ago |
|
|
CMMB
12
Chemomab Therapeutics
CMMB
$16M
| $3.09 | $120 |
3,784%
upside
| Buy |
7 Dec ‘21
3 years ago |
|
13
Inspira Technologies Oxy
IINN
$37.3M
| $1.21 | $10 |
726%
upside
| Buy |
1 Nov ‘21
3 years ago |
|
|
HURA
14
TuHURA Biosciences, Inc. Common Stock
HURA
$128M
| $2.55 | $8,750 |
343,037%
upside
| Buy |
30 Sep ‘21
3 years ago |
|
15
Cidara Therapeutics
CDTX
$1.6B
| $63.17 | $160 |
153%
upside
| Buy |
22 Sep ‘21
4 years ago |
|
16
Xoma
XOMA
$426M
| $35.24 | $56 |
59%
upside
| Buy |
9 Sep ‘21
4 years ago |
|
17
ATAI Life Sciences
ATAI
$980M
| $4.57 | $27 |
491%
upside
| Buy |
17 Aug ‘21
4 years ago |
|
|
18
ATAI Life Sciences
ATAI
$980M
| $4.57 | $27 |
491%
upside
| Buy |
17 Aug ‘21
4 years ago |
|
19
SCYNEXIS
SCYX
$37.3M
| $0.8900 | $35 |
3,833%
upside
| Buy |
7 Jun ‘21
4 years ago |
|
20
Entera Bio
ENTX
$94.1M
| $2.06 | $12 |
483%
upside
| Buy |
22 Mar ‘21
4 years ago |
|
21
Greenwich LifeSciences
GLSI
$149M
| $10.93 | $75 |
586%
upside
| Buy |
26 Jan ‘21
4 years ago |
|
22
Biomerica
BMRA
$7.74M
| $2.75 | $88 |
3,100%
upside
| Buy |
19 Oct ‘20
4 years ago |
|
23
VistaGen Therapeutics
VTGN
$109M
| $3.55 | $180 |
4,970%
upside
| Buy |
8 Oct ‘20
4 years ago |
|
|
GRCE
24
Grace Therapeutics, Inc. Common Stock
GRCE
$44.3M
| $3.20 | $12 |
275%
upside
| Hold |
2 Sep ‘20
5 years ago |
|
25
Ekso Bionics
EKSO
$10.6M
| $4.04 | $135 |
3,242%
upside
| Buy |
3 Aug ‘20
5 years ago |
|